Limits of 18F-Fluorodeoxyglucose positron emission tomography in recurrence diagnosis of borderline ovarian tumor

Margherita Giorgini, Claudia Marchetti, Violante Di Donato, Jacopo Tesei, Natalina Manci, Pierluigi Benedetti Panici

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Most borderline ovarian tumors (BOT) occur in young women and exhibit a low malignant behavior. Nevertheless, an accurate long-term follow-up is required because, frequently, recurrence arises after many years from primary treatment, especially in patients affected by BOTwith invasive peritoneal implants, which have aworse prognosis.We report the case of a pelvic recurrence of serous BOT firstly suspected by physical examination but misdiagnosed by 18F-fluorodeoxyglucose positron emission tomography and computed tomography and identified only by magnetic resonance imaging, 7 years after primary treatment. We also reviewed the literature concerning the role of 18F-fluorodeoxyglucose positron emission tomography in the management and follow-up of BOT. Copyright © 2010 by IGCS and ESGO.
Lingua originaleEnglish
pagine (da-a)694-697
Numero di pagine4
RivistaInternational Journal of Gynecological Cancer
Volume20
DOI
Stato di pubblicazionePubblicato - 2010

Keywords

  • Borderline ovarian tumors
  • Recurrence
  • Total-body FDG-PET/CT

Fingerprint

Entra nei temi di ricerca di 'Limits of 18F-Fluorodeoxyglucose positron emission tomography in recurrence diagnosis of borderline ovarian tumor'. Insieme formano una fingerprint unica.

Cita questo